-- The ability to identify up to 23 different species of bacteria
including MRSA (Methicillin Resistant Staphylococcus aureus), E.coli,
Salmonella and Listeria -- all of which are frequently reported
contamination cases found in food processing, food products, hospitals
and other public places.
-- Identification occurs in less than 10 minutes after completion of the
culturing process without using chemicals, reagents or DNA processing.
-- Culture time is usually twice as fast as typical laboratory standards
due to the small amount of organisms needed to identify the bacteria.
-- The End User does not need to have prior knowledge of the species
before starting the test. As long as the bacteria species is in the
System's database, identification will be made.
-- Projected cost per test is less than 10 cents.
"We are pleased to have been recognized by the ABL organization for the MIT
1000 System's potential value to society and are looking forward to ABL's
Finalist selection in April 2008," stated Michael Brennan, MIT's Chairman.
About Adaptive Business Leaders Organization
Celebrating its 25th anniversary year, the Adaptive Business Leaders (ABL)
Organization's mission is to help health and technology leaders grow great
companies. ABL does this through its eight monthly, industry-specific Round
Tables held throughout California, and frequent Conferences, Workshops and
Events. In their confidential Round Tables, ABL Members -- who are CEOs,
Presidents, COOs and Division General Managers of Health and Technology
companies -- openly seek from and share with each other candid advice, best
practices and innovative approaches for capitalizing on market trends and
opportunities, in order to assure they are well positioned for business and
personal success.
About Micro Imaging Technology
The Company has developed and patented a technology for rapid microbe
detection and identification. This System measures scattered light
intensity as individual microbes pass through a laser beam. The intensity
pattern of the scattered light is a direct consequence of the size, shape
and external and internal optical characteristics of the microbe. The MIT
System is non-biological and does not rely on biological agents,
conventional chemical processing, fluorescent tags, gas chromatography or
DNA analysis.
MIT has demonstrated the ability to detect and identify, within several
minutes, the microbes Escherichia coli, Listeria, Salmonella,
Staphylococcus aureus, Shigella and other pathogenic bacteria. The
identification process has been verified by North American Science
Associates, Inc. (NAMSA), an independent, internationally recognized
biological testing laboratory. The NAMSA Test Report, in the Company's
opinion, demonstrated the accuracy, speed and efficiency of the MIT System
over conventional processes and is available from the Company. The MIT
1000 System was recently featured in a Rapid Microbiology international
newsletter and can be viewed at
http://www.rapidmicrobiology.com/news/1231h0.php?s=MIT.
This release contains statements that are forward-looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made
based upon information available to the Company as of the date of this
release, and we assume no obligation to update any such forward-looking
statements. These statements are not guarantees of future performance and
actual results could differ materially from our current expectations.
Factors that could cause or contribute to such differences include, but are
not limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.
Contact Information: CONTACT: Michael Brennan Chairman Email: Telephone: (805) 557-0614